Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Oncotarget · 2017 · PMC5355355 · PMID 27926493

Europe PMC DOI

hedged sentence

0.2600

closest p · 5.2× alpha

0.2600

boldest claim

The sentences

did not reach statistical significancep = 0.26not close (p > 0.1)

Although at 32%, the MYC amplification in IBC appeared to represent enrichment in this tumor type, comparison with the 24% MYC amplification rate in the non-IBC breast cancers did not reach statistical significance ( p = 0.26) [ 39 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.